NCT06577896

The Study to Evaluate the Safety and Efficacy of the Onyx Family

Safety and Efficacy of 1-month Dual Antiplatelet Therapy in High Bleeding and Ischemic Risk Elderly Patients With Coronary Artery Disease After Implantation of Zotarolimus-eluting Coronary Stent System (Onyx Family, Medtronic, Minneapolis, MN); A Multicenter, Prospective, Observational Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Pusan National University Yangsan Hospital · Academic / Other
• Sex: All
• Age: 75 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

Observation of the safety and efficacy of 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention using Onyx family stents in elderly patients aged 75 years or older

Detailed description

For elderly patients aged 75 years or older undergoing percutaneous coronary intervention with Onyx family drug-eluting stents, observe the safety and efficacy of transitioning from dual antiplatelet therapy to single therapy for one year after one month of dual antiplatelet therapy

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Onyx family	Safety and Efficacy of 1-Month DAPT in Elderly Patients at High Risk of Ischemia and Bleeding After Percutaneous Coronary Intervention with Onyx Family Stents

Timeline

• Start date: 2022-06-09
• Primary completion: 2026-01-31
• Completion: 2026-12-31
• First posted: 2024-08-29
• Last updated: 2024-09-19

Locations

1 site across 1 country: South Korea